FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W91709581> ?p ?o ?g. }

• W91709581 endingPage "1599" @default.
• W91709581 startingPage "1592" @default.
• W91709581 abstract "The purpose of this study was to compare 600- and 300-mg clopidogrel loading doses in patients with ST-segment elevation myocardial infarction (STEMI).Given the high thrombotic risk of patients with STEMI, greater platelet inhibition may improve outcome in those patients receiving percutaneous coronary intervention (PCI). Although observational data suggest that pretreatment with a 600-mg clopidogrel loading dose may be more effective than the 300-mg regimen in primary PCI, this hypothesis has never been tested in a randomized study.A total of 201 patients undergoing primary PCI for STEMI randomly received a 600-mg (n = 103) or 300-mg (n = 98) clopidogrel loading dose before the procedure. The primary endpoint was the evaluation of the infarct size, defined as the area under the curve of cardiac markers.Infarct size was significantly lower in the high-dose regimen: median creatine kinase-myocardial band 2,070 ng/ml (interquartile range [IQR]: 815 to 2,847 ng/ml) versus 3,049 ng/ml (IQR: 1,050 to 7,031 ng/ml) in the 300-mg group, p = 0.0001; troponin-I 255 ng/ml (IQR: 130 to 461 ng/ml) versus 380 ng/ml (IQR: 134 to 1,406 ng/ml), p < 0.0001. In the 600-mg arm, Thrombolysis In Myocardial Infarction flow grade <3 after PCI was less frequent (5.8% vs. 16.3%, p = 0.031), left ventricular ejection fraction at discharge was improved (52.1 ± 9.5% vs. 48.8 ± 11.3%, p = 0.026), 30-day major adverse cardiovascular events were fewer (5.8% vs. 15%, p = 0.049), and bleeding/entry site complications were not increased (secondary endpoints).In STEMI patients, pre-treatment with a 600-mg clopidogrel loading dose before primary PCI was associated with a reduction of the infarct size compared with a 300-mg loading dose, as well as with improvement of angiographic results, residual cardiac function, and 30-day major adverse cardiovascular events; further studies are warranted to evaluate impact of such strategy on survival." @default.
• W91709581 created "2016-06-24" @default.
• W91709581 creator A5007714575 @default.
• W91709581 creator A5012259635 @default.
• W91709581 creator A5022223006 @default.
• W91709581 creator A5033359462 @default.
• W91709581 creator A5033373672 @default.
• W91709581 creator A5051416813 @default.
• W91709581 creator A5051460073 @default.
• W91709581 creator A5060727278 @default.
• W91709581 creator A5067713609 @default.
• W91709581 creator A5080387278 @default.
• W91709581 creator A5080624140 @default.
• W91709581 creator A5086692319 @default.
• W91709581 date "2011-10-01" @default.
• W91709581 modified "2023-10-08" @default.
• W91709581 title "Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction" @default.
• W91709581 cites W101302537 @default.
• W91709581 cites W125388946 @default.
• W91709581 cites W1421247184 @default.
• W91709581 cites W1569796594 @default.
• W91709581 cites W194270601 @default.
• W91709581 cites W2001688139 @default.
• W91709581 cites W2017958214 @default.
• W91709581 cites W2039400286 @default.
• W91709581 cites W2041936661 @default.
• W91709581 cites W2049120615 @default.
• W91709581 cites W2052106438 @default.
• W91709581 cites W2053379248 @default.
• W91709581 cites W2060607835 @default.
• W91709581 cites W2075358198 @default.
• W91709581 cites W2084673482 @default.
• W91709581 cites W2085869089 @default.
• W91709581 cites W2090877265 @default.
• W91709581 cites W2099409915 @default.
• W91709581 cites W2102920012 @default.
• W91709581 cites W2104549091 @default.
• W91709581 cites W2104595603 @default.
• W91709581 cites W2105197242 @default.
• W91709581 cites W2110108344 @default.
• W91709581 cites W2113350818 @default.
• W91709581 cites W2124788115 @default.
• W91709581 cites W2127042742 @default.
• W91709581 cites W2130350603 @default.
• W91709581 cites W2144206796 @default.
• W91709581 cites W2150086052 @default.
• W91709581 cites W2150740314 @default.
• W91709581 cites W2156637699 @default.
• W91709581 cites W2162547222 @default.
• W91709581 cites W2169387542 @default.
• W91709581 cites W2336211246 @default.
• W91709581 cites W2429966773 @default.
• W91709581 cites W4235858444 @default.
• W91709581 cites W4376848313 @default.
• W91709581 cites W54228213 @default.
• W91709581 cites W67811773 @default.
• W91709581 doi "https://doi.org/10.1016/j.jacc.2011.06.044" @default.
• W91709581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21958886" @default.
• W91709581 hasPublicationYear "2011" @default.
• W91709581 type Work @default.
• W91709581 sameAs 91709581 @default.
• W91709581 citedByCount "106" @default.
• W91709581 countsByYear W917095812012 @default.
• W91709581 countsByYear W917095812013 @default.
• W91709581 countsByYear W917095812014 @default.
• W91709581 countsByYear W917095812015 @default.
• W91709581 countsByYear W917095812016 @default.
• W91709581 countsByYear W917095812017 @default.
• W91709581 countsByYear W917095812018 @default.
• W91709581 countsByYear W917095812019 @default.
• W91709581 countsByYear W917095812020 @default.
• W91709581 countsByYear W917095812021 @default.
• W91709581 countsByYear W917095812022 @default.
• W91709581 crossrefType "journal-article" @default.
• W91709581 hasAuthorship W91709581A5007714575 @default.
• W91709581 hasAuthorship W91709581A5012259635 @default.
• W91709581 hasAuthorship W91709581A5022223006 @default.
• W91709581 hasAuthorship W91709581A5033359462 @default.
• W91709581 hasAuthorship W91709581A5033373672 @default.
• W91709581 hasAuthorship W91709581A5051416813 @default.
• W91709581 hasAuthorship W91709581A5051460073 @default.
• W91709581 hasAuthorship W91709581A5060727278 @default.
• W91709581 hasAuthorship W91709581A5067713609 @default.
• W91709581 hasAuthorship W91709581A5080387278 @default.
• W91709581 hasAuthorship W91709581A5080624140 @default.
• W91709581 hasAuthorship W91709581A5086692319 @default.
• W91709581 hasBestOaLocation W917095811 @default.
• W91709581 hasConcept C119060515 @default.
• W91709581 hasConcept C126322002 @default.
• W91709581 hasConcept C164705383 @default.
• W91709581 hasConcept C2777849778 @default.
• W91709581 hasConcept C2777995511 @default.
• W91709581 hasConcept C2778198053 @default.
• W91709581 hasConcept C2779581417 @default.
• W91709581 hasConcept C2780400711 @default.
• W91709581 hasConcept C2781413609 @default.
• W91709581 hasConcept C35294091 @default.
• W91709581 hasConcept C45393284 @default.

• next